PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Brian I. Rini, MD, FASCO - Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Visit https://www.peervoice.com/EDH860 to view the entire programme with slides. After completing “Brian I. Rini, MD, FASCO - Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma”, participants will be able to: Evaluate available evidence for emerging triplet combination therapies in advanced renal cell carcinoma (RCC); Use patient-, disease-, and treatment-related characteristics to ensure optimal, personalized care of patients with advanced RCC; and Propose evidence-based practical strategies to identify and manage common and serious adverse events associated with combination therapies in patients with RCC.